Executive Profile

Randall E. Woods Chief Executive Officer, President and Director, Sophiris Bio, Inc.

Age	Total Calculated Compensation	This person is connected to 8 Board Members in 8 different organizations across 9 different industries. See Board Relationships
60	$965,847 As of Fiscal Year 2012

Background

Mr. Randall E. Woods, Randy has been the Chief Executive Officer of Sophiris Bio, Inc., since August 16, 2012 and serves as its President. Mr. Woods founded and served as the President and Chief Executive Officer of Sequel Pharmaceuticals, Inc. Mr. Woods served as President and Chief Executive Officer of Novacardia, Inc. since May 2004. He served as President and Chief Executive Officer of Corvas International Inc. until 2003. Prior to joining Corvas, Mr. Woods served ... as the President of the U.S. Operations, Boehringer Mannheim Pharmaceuticals Corporation, or Boehringer, from February 1994 to March 1996, and was Vice President of Marketing and Sales from December 1993 to March 1994. He has been Chairman of the Board of Sorbent Therapeutics, Inc. since April 2012. Mr. Woods founded and serves as Chairman of the Board of Selexagen Therapeutics, Inc. Mr. Woods is a past Chairman for the Advisory Board of UC San Diego's Sulpizio Family Cardiovascular Center and is a past Chairman of the Board of Directors for BIOCOM, a life science industry association in Southern California. He serves as a Director of Biocom SA and Sequel Pharmaceuticals, Inc. He has been a director at Sophiris Bio, Inc. since October 2012. He has been a Director of Novacardia, Inc. since May 2004. He has been an Independent Director of Arena Pharmaceuticals, Inc. December 2007. He serves as Member of the Business Advisory Board of Ultreia Capital. Mr. Woods serves as a Director of Oasis Biosciences, Inc. He serves as Member of the Business Advisory Board at affentranger associates sa, Investment arm. Prior to that, he served in various capacities at Eli Lilly and Company from 1973 to December 1993. He served as a Director of Corvas International, Inc. since May 1996. Mr. Woods holds an M.B.A. from Western Michigan University in Marketing and BSc in Biology and Chemistry from Chemistry.

Corporate Headquarters 12264 El Camino Real San Diego, California 92130 United States Phone: 619-252-4024 Fax: -- Board Members Memberships Director Biocom SA Director BIOCOM, Inc. Director Sequel Pharmaceuticals, Inc. Founder and Chairman of the Board Selexagen Therapeutics, Inc. 1996-N/A Former Chief Executive Officer, President and Director Corvas International, Inc 2004-N/A Former Chief Executive Officer, President and Director NovaCardia, Inc. 2007-Present Independent Director and Member of Compensation Committee Arena Pharmaceuticals, Inc. 2012-Present Chief Executive Officer, President and Director Sophiris Bio, Inc. 2012-Present Chairman Sorbent Therapeutics, Inc. Education BS Ball State University MBA Western Michigan University Other Affiliations Arena Pharmaceuticals, Inc. Corvas International, Inc Biocom SA NovaCardia, Inc. affentranger associates sa, Investment arm Ball State University Western Michigan University BIOCOM, Inc. Sorbent Therapeutics, Inc. Sequel Pharmaceuticals, Inc. Selexagen Therapeutics, Inc.

Annual Compensation Salary $159,375 Total Annual Compensation $159,375 Stocks Options All Other Compensation $18,487 Total Number of Options $4,913,796 Total Compensation Total Annual Cash Compensation $177,862 Total Short Term Compensation $159,375 Other Long Term Compensation $18,487 Total Calculated Compensation $965,847

COMPETITOR COMPENSATION

Name	Position/ Company	Compensation
M. Philippe Archinard Ph.D.	Chairman and Chief Executive Officer Transgene SA	$69.2K
Kjetil Hestdal M.D., Ph.D.	Chief Executive officer and President PhotoCure ASA	$2.1M
Eugene Seymour M.D., MPH	Chief Executive Officer and Director NanoViricides, Inc.	$275.0K
Compensation as of Fiscal Year 2011.